Stock Track | Cellebrite Stock Soars 13.65% After Hours on Strong Q3 Results and Positive Outlook

Stock Track
11/13

Cellebrite (CLBT) shares surged 13.65% in after-hours trading on Wednesday following the release of its third-quarter 2025 financial results, which exceeded analyst expectations and showcased robust growth across key business segments.

The digital investigative solutions provider reported Q3 revenue of $126.03 million, beating the consensus estimate of $122.01 million and representing an 18% year-over-year increase. Adjusted EBITDA also outperformed, coming in at $37.74 million compared to the expected $32.18 million, reflecting a strong operational performance with a 29.9% adjusted EBITDA margin.

Cellebrite's CEO, Thomas E. Hogan, highlighted the company's balanced and solid performance, noting significant expansion within the U.S. Federal business segment. "We exceeded the high end of our prior adjusted EBITDA guidance with revenue at the high end of expectations," Hogan stated. The company's execution demonstrated resilience and the growing importance of its solutions to global public safety initiatives.

Key drivers of the quarter's success included a 21% growth in subscription revenue, fueled by strong demand in U.S. state and local markets, as well as in Latin America. The company also announced its Autumn 2025 Release, introducing new capabilities and integrations that enhance its Digital Investigation Platform, further solidifying its market position.

Looking ahead, Cellebrite provided an optimistic outlook for the remainder of 2025 and beyond. The company expects full-year 2025 revenue between $470 million and $475 million, representing a 17% to 18% annual growth. Additionally, Cellebrite anticipates Q4 2025 adjusted EBITDA in the range of $35 million to $38 million, signaling continued strong performance.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10